Advertisement

Topics

Cryopreserved formulation of retinal stem cell therapy approved by FDA

11:06 EDT 19 Jun 2017 | EPM Magazine

ReNeuron Group has announced that the FDA has approved the cryopreserved formulation of its human retinal progenitor cell (hRPC) therapeutic candidate, which enables it to be frozen for shipping and storage and thawed at the point of clinical use.

Original Article: Cryopreserved formulation of retinal stem cell therapy approved by FDA

NEXT ARTICLE

More From BioPortfolio on "Cryopreserved formulation of retinal stem cell therapy approved by FDA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...